Danaher outlines 3% core revenue growth and $7.60-$7.75 EPS guidance for 2025

Earnings Call Insights: Danaher Corporation (DHR) Q1 2025

Management View

  • CEO Rainer Blair highlighted that Q1 revenue, earnings, and cash flow exceeded expectations, with momentum in bioprocessing and higher-than-anticipated respiratory demand at Cepheid. He emphasized the resilience of Danaher’s portfolio, noting that over 80% of revenues

Leave a Reply

Your email address will not be published. Required fields are marked *